In a new study towards advancing cancer treatment, researchers at The University of Texas at El Paso (UTEP) have discovered a new drug with the potential to effectively combat leukemia and lymphoma.
This pioneering research, led by Professor Renato Aguilera, Ph.D., was recently published in the journal PLOS One.
This discovery not only brings new hope in the fight against cancer but also provided valuable training for five Ph.D. students who are now contributing to research nationwide as postdoctoral fellows.
Leukemia and lymphoma, cancers of the blood cells and the immune system respectively, have long been targets for medical research.
Aguilera’s team embarked on a mission to screen various drug compounds, testing their effects on cancer cell types.
In the vast sea of compounds generated by pharmaceutical companies, many with unknown or unclear uses, Aguilera’s team sought to identify those with specific effects on human cells.
Among the 1,300 compounds tested, thiophene F-8 emerged as a highly effective agent, inducing programmed cell death in leukemia and lymphoma cells.
By triggering a self-destruct mechanism within the cancer cells and inhibiting new cancer cell growth, thiophene F-8 represents a promising leap forward in cancer therapy.
As the team delves further into studying thiophene F-8’s effectiveness, there’s growing anticipation about its future applications.
Should the compound prove successful in ongoing tests, it may prompt pharmaceutical companies to initiate clinical studies, potentially marking a new chapter in the treatment of leukemia and lymphoma.
This discovery exemplifies the power of academic research in spearheading medical advancements and offers renewed hope for more effective cancer treatments in the near future.
If you care about cancer, please read studies about a new method to treat cancer effectively, and this low-dose, four-drug combo may block cancer spread.
For more information about cancer prevention, please see recent studies about nutrient in fish that can be a poison for cancer, and results showing this daily vitamin is critical to cancer prevention.
The research findings can be found in PLOS ONE.
Copyright © 2024 Knowridge Science Report. All rights reserved.
